You are here: Industry Insights > BioNTech

News List

AGC Biologics Inks Supply Deal for COVID-19 Vaccine contractpharma
June 08, 2021
CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.
Pfizer/BioNTech COVID-19 vaccine approved for young people in Switzerland firstwordpharma
June 07, 2021
Swissmedic approves indication extension for Comirnaty® for 12 to 15-year-olds
Pfizer Covid-19 vaccine approved for adolescents in the UK pharmaceutical-technology
June 07, 2021
The approval of Pfizer and BioNTech’s Covid-19 vaccine COMIRNATY in the UK has been expanded to include individuals between 12 and 15 years of age.
Vaccine Protection May Diminish Need for Yearly Boosters firstwordpharma
June 03, 2021
Scientists have found clues that the world's leading COVID-19 vaccines offer lasting protection that could reduce the need for frequent booster shots, as reported in U.S. News & World Report.
Siegfried starts to ramp up production after cyber attack cphi-online
June 02, 2021
Hameln plant which provides fill and finish for Pfizer-BioNTech COVID-19 shot should be fully operational within the week, CDMO says
Terry Gou to bid for Pfizer-BioNTech shots purchase before June 1 firstwordpharma
June 01, 2021
Taiwan, Chinaese billionaire businessman Terry Gou announced Sunday that he is putting together a bid to purchase the Pfizer-BioNTech COVID-19 vaccines for Taiwan, China that will be submitted within 72 hours, reported The China Post.
EU authorises Pfizer-BioNTech Covid-19 vaccine in adolescents pharmaceutical-technology
May 31, 2021
Pfizer and BioNTech have received expanded Conditional Marketing Authorization (CMA) in the European Union (EU) for their Covid-19 vaccine, Comirnaty, to include people aged 12 to 15 years.
Pfizer Explors Coadministration of Its 20-valent Pneumococcal Vaccine With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine americanpharmaceuticalreview
May 28, 2021
Pfizer announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the coadministration of the company’s 20-valent pneumococcal conjugate vaccine (20vPnC) candidate ...
MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid Demand contractpharma
May 27, 2021
MilliporeSigma has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule to meet high demand for lipids, a key component of mRNA-based vaccines and therapeutics.
EC to procure 1.8 billion doses of Pfizer-BioNTech’s Covid-19 vaccine pharmaceutical-technology
May 24, 2021
The European Commission (EC) has signed a new contract with BioNTech and Pfizer to procure additional 1.8 billion doses of their Covid-19 vaccine, Comirnaty, between this year end to 2023.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page